Article
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.
Nature communications - 26 Jul 2021
Ikegame Satoshi, Siddiquey Mohammed N A, Hung Chuan-Tien, Haas Griffin, Brambilla Luca, Oguntuyo Kasopefoluwa Y, Kowdle Shreyas, Chiu Hsin-Ping, Stevens Christian S, Vilardo Ariel Esteban, Edelstein Alexis, Perandones Claudia, Kamil Jeremy P, Lee Benhur
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected at least 180 million people since its identification as the cause of the current COVID-19 pandemic. The rapid pace of vaccine development has resulted in multiple vaccines already in use worldwide. The contemporaneous emergence of SARS-CoV-2 'variants of concern' (VOC) across diverse geographic locales underscores the need to monitor the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.